Literature DB >> 34123414

The Analysis of Dynamic Changes and Prognosis of Posner-Schlossman Syndrome with Cytomegalovirus Infection and Antiviral Therapy.

Qilian Sheng1,2,3, Ruyi Zhai1,2,3, Xintong Fan1,2,3, Xiangmei Kong1,2,3.   

Abstract

PURPOSE: To analyze how keratic precipitate (KP) morphology changes during Posner-Schlossman syndrome (PSS) prognosis and raise medication suggestions on 2% ganciclovir eye drops.
MATERIALS AND METHODS: Clinical retrospective cohort study in the Eye & ENT Hospital of Fudan University, Shanghai, China. The attacked eyes of 98 eligible subjects diagnosed unilateral PSS were enrolled between 2016 and 2019. All patients were treated with intraocular pressure-lowering drugs and anti-inflammatory steroids. 2% ganciclovir eye drops were given to cytomegalovirus (CMV) immunoglobulin G (IgG) correction ratio positive patients. Frequent follow-ups and examinations were performed. KP morphology was focused and categorized into coin-shaped, mutton-fat, and pigmented. Medical histories were noted. Multidimensional analysis was given.
RESULTS: Totally 47 patients in 98 achieved all-KP disappearance. Mean treatment time was (5.13 ± 3.66) weeks. Total KP disappearance was negatively correlated with mutton-fat and pigmented KPs at the first visit (P=0.020, P=0.007) and treatment time was also longer (P=0.018, P=0.014). Mean cumulative steroids dosage for 47 subjects was (159.66 ± 161.84) drops. CMV IgG correction ratio positive patients had smaller corneal endothelial cell density (P < 0.005) and larger cup-to-disc ratio (P=0.017) than negative subjects. Cumulative steroid treatment time was longer in the CMV-positive group, and overall dosage was also larger. However, due to 2% ganciclovir eye drops, daily steroid dosage was lower in the CMV-positive group.
CONCLUSIONS: The disappearance of mutton-fat and pigmented KPs needed longer treatment time. Paired aqueous humor and serum CMV IgG tests were recommended in PSS patients with coin-shaped KPs. 2% ganciclovir eye drops improved prognosis; and steroids dosage reduced significantly.
Copyright © 2021 Qilian Sheng et al.

Entities:  

Year:  2021        PMID: 34123414      PMCID: PMC8189808          DOI: 10.1155/2021/6687929

Source DB:  PubMed          Journal:  J Ophthalmol        ISSN: 2090-004X            Impact factor:   1.909


  24 in total

Review 1.  Infectious theories of Posner-Schlossman syndrome.

Authors:  Hana L Takusagawa; Yao Liu; Janey L Wiggs
Journal:  Int Ophthalmol Clin       Date:  2011

2.  Topical Ganciclovir in Cytomegalovirus Anterior Uveitis.

Authors:  Joelle Antoun; François Willermain; Dorine Makhoul; Elie Motulsky; Laure Caspers; Lia Judice Relvas
Journal:  J Ocul Pharmacol Ther       Date:  2017-04-20       Impact factor: 2.671

Review 3.  Clinical Features of CMV-Associated Anterior Uveitis.

Authors:  Nicole Shu-Wen Chan; Soon-Phaik Chee; Laure Caspers; Bahram Bodaghi
Journal:  Ocul Immunol Inflamm       Date:  2017-11-27       Impact factor: 3.070

4.  Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy.

Authors:  Chien-Chia Su; Fung-Rong Hu; Tsing-Hong Wang; Jehn-Yu Huang; Po-Ting Yeh; Chang-Ping Lin; I-Jong Wang
Journal:  Am J Ophthalmol       Date:  2014-08-12       Impact factor: 5.258

Review 5.  Ocular manifestations of cytomegalovirus in immunocompetent hosts.

Authors:  Ashlin Joye; John A Gonzales
Journal:  Curr Opin Ophthalmol       Date:  2018-11       Impact factor: 3.761

6.  Keratic precipitate morphology in uveitic syndromes including Behçet's disease as evaluated with in vivo confocal microscopy.

Authors:  M C Mocan; S Kadayifcilar; M Irkec
Journal:  Eye (Lond)       Date:  2008-07-25       Impact factor: 3.775

7.  Immunoglobulin E in aqueous humour.

Authors:  J P Dernouchamps; C G Magnusson; J Michiels; P L Masson
Journal:  Exp Eye Res       Date:  1985-02       Impact factor: 3.467

8.  PCR Multiplex for CMV Detection in Patients with Anterior Uveitis.

Authors:  Alexandra Martín Ramírez; Laura Cardeñoso Domingo; J Jacobo González Guijarro
Journal:  Ocul Immunol Inflamm       Date:  2018-02-23       Impact factor: 3.070

9.  Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study.

Authors:  Noriko Koizumi; Tsutomu Inatomi; Takashi Suzuki; Atsushi Shiraishi; Yuichi Ohashi; Michiko Kandori; Dai Miyazaki; Yoshitsugu Inoue; Takeshi Soma; Kohji Nishida; Hiroshi Takase; Sunao Sugita; Manabu Mochizuki; Shigeru Kinoshita
Journal:  Br J Ophthalmol       Date:  2014-07-29       Impact factor: 4.638

10.  Relationships between the clinical characteristics and copy numbers of DNA of cytomegalovirus determined by real-time PCR.

Authors:  Ayano Yoshimura; Kaoru Araki-Sasaki; Noriko Toyokawa; Rho Fujiwara; Nobuo Jho; Fumi Gomi
Journal:  Int Ophthalmol       Date:  2020-05-16       Impact factor: 2.031

View more
  1 in total

1.  Long-Term Outcome of Treatment with 2% Topical Ganciclovir Solution in Cytomegalovirus Anterior Uveitis and Corneal Endotheliitis.

Authors:  Po-Jui Chen; I-Huang Lin; Yi-Chun Chi; Chun-Chieh Lai; Jia-Horung Hung; Sung-Huei Tseng; Yi-Hsun Huang
Journal:  Infect Drug Resist       Date:  2022-06-29       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.